Skip to content

Chronic Hepatitis C

Chronic hepatitis C is a long-lasting infection caused by the hepatitis C virus. The virus stays in the body and does not clear on its own. Over time, the infection can affect the liver.

Medicine used to treat Chronic Hepatitis C

Copegus

Ribavirin

100mg

Copegus contains ribavirin and is a film-coated tablet used in the management of chronic hepatitis C. It comes in one strength, with pack sizes available. You see the price per tablet for each option.

FromUS$4.86/ tabletView

Key points

  • Most people infected with the hepatitis C virus develop a chronic infection; more than half of acute cases progress to the chronic form.
  • Chronic hepatitis C is a leading cause of liver cancer and liver transplants in the United States.
  • Antiviral medicines can cure more than 95% of people with chronic hepatitis C in 8 to 12 weeks.

What chronic hepatitis C is

The infection is chronic when the hepatitis C virus stays in the body rather than going away. Over time, the virus can continue to affect the liver. Cirrhosis is a complication in which scar tissue replaces healthy liver tissue, prevents the liver from working normally and partly blocks blood flow through the liver.

Symptoms

People with chronic hepatitis C usually have few or no symptoms. Some notice general problems such as chronic tiredness or depression. Serious problems may not be noticed until cirrhosis or other liver complications develop, which can be decades after infection.

Treatment

Chronic hepatitis C can be treated with antiviral medicines, which cure more than 95% of people in 8 to 12 weeks. Copegus (ribavirin) 100mg tablets contain ribavirin and are used for chronic hepatitis C. Ribavirin is the ingredient (ribavirin), and the antivirals category groups related medicines. Orders are shipped to Malaysia from pharmacy partners in India in discreet packaging.

When to see a doctor

Seek medical advice if you have ongoing tiredness or depression that concerns you, or if you have been diagnosed with hepatitis C. Symptoms may not appear until decades after infection, so do not wait for signs of cirrhosis before discussing treatment.

What the sources say

  • Researchers estimate that more than 2 million people in the United States still have chronic hepatitis C, and the number is falling as effective therapies become available. (NIDDK)
  • Without treatment, chronic hepatitis C can cause liver disease, liver failure, liver cancer and death. (CDC)

Further reading

Last updated